主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SUPN
#1407
Supernus Pharmaceuticals, Inc.
54.730
0
+0.48%
版块:
基础:
利润货币:
日范围
年范围
日变化
+0.48%
每月变动
+10.77%
6个月变化
+1.35%
年变化
+1.35%
前一天收盘价
54.470
0
Open
54.730
0
Bid
Ask
Low
54.730
0
High
54.730
0
交易量
97
市场
股票
医疗保健
SUPN
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
55.22 M
55.81 M
55.99 M
56.07 M
57.34 M
—
Valuation ratios
Enterprise value
1.69 B
1.95 B
1.72 B
1.62 B
2.59 B
7.88 B
Price to earnings ratio
28.61
27.39
29.5
27.41
-140.56
-56.25
Price to sales ratio
2.67
3.06
2.74
2.66
3.95
12.4
Price to cash flow ratio
10.07
11.77
11.15
9.47
37.21
69.6
Price to book ratio
0.46
1.95
0.45
0.43
0.64
3.48
Enterprise value to EBITDA ratio
5.5
3.57
6.84
6.56
17.69
34.66
Profitability ratios
Return on assets %
0.03
0.01
-0.01
-0
0
0
Return on equity %
0.04
0.01
-0.01
-0
0
0
Return on invested capital %
9.81
4.03
0.1
-1.89
9.66
11.91
Gross margin %
89.99
85.01
89.48
89.83
90.13
354.45
Operating margin %
19.66
12.29
-6.85
-5.06
18.71
19.1
EBITDA margin %
51.41
35
27.61
33.13
-5.62
90.12
Net margin %
21.91
8.8
-7.89
-0.7
0.06
0.27
Liquidity ratios
Quick ratio
1.98
2.16
2.26
2.43
1.47
8.32
Current ratio
2.2
2.35
2.44
2.58
1.8
9.16
Inventory turnover
0.27
0.44
0.3
0.36
0.25
1.36
Asset turnover
0.13
0.13
0.11
0.12
0.14
0.5
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.96
0.79
0.55
1.03
-1.1
1.28
EBIT per share
1.26
0.75
0.38
0.59
-0.63
1.08
EBITDA per share
1.62
1.09
0.74
0.97
-0.19
2.6
Total debt per share
—
—
—
—
—
—
Cash per share
0.57
1.24
2.07
2.55
2.7
8.56
Net current asset value per share
11.47
12.26
12.31
13.03
10.58
48.18
Tangible book value per share
6.27
7.09
7.37
8.21
5.47
28.14
Working capital per share
6.25
7.04
7.26
7.98
4.69
26.97
Book value per share
18.05
18.51
18.45
18.77
18.7
74.43
新闻
TD Cowen上调Supernus Pharmaceuticals目标价,看好Onapgo重新上市
TD Cowen raises Supernus Pharmaceuticals stock price target on Onapgo relaunch
Supernus Pharmaceuticals股价触及52周高点57.76美元
Supernus Pharmaceuticals stock hits 52-week high at $57.76
Cantor Fitzgerald维持Supernus股票增持评级,看好供应增长
Cantor Fitzgerald reiterates Supernus stock Overweight on supply gains
Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates
Supernus Pharmaceuticals Q4 每股收益 逊于预期, 营收 超出预期
Supernus earnings missed by $0.48, revenue topped estimates
Supernus财报考验:第三季度盈利能力受挫后迎来关键测试
Supernus faces earnings test after Q3 shock to profitability
Earnings Preview: Supernus Pharmaceuticals (SUPN) Q4 Earnings Expected to Decline